Cancer Research
With the ongoing support of our generous donors and partners, we have helped fund research into childhood cancer for over 27 years
Our vision, ‘a world where a child’s cancer diagnosis is an unremarkable event in life’, cannot be realised without partnering with research and breakthrough treatments that will deliver game-changing outcomes in the future of cancer care.
If there is anything to be positive about regarding paediatric cancer, it is the advancements in therapies and treatments that are happening right now with the support of Kids with Cancer Foundation and others. Kids with Cancer Foundation has already committed to exciting research projects that target childhood cancers which we expect, in time, will become the standard of care for patients and deliver even better treatment and outcomes in Australia.
Our impact
in 2024
FY24 figures
Children’s hospitals across Australia received funding for research
Committed to funding for the Kids with Cancer Foundation Genetic Risk Program
Annual contribution – part of our 5-year commitment as principal funder of Ependymoma research
From funding a world-first clinical trial for brain cancer using an Australian drug, to establishing the Kids with Cancer Genetic Risk Program at The Children’s Hospital Westmead, we have been involved in many innovative programs that aim to help families and clinicians make informed decisions about the future of cancer treatment.
While it is too early to be able to report any medical outcomes from this trial, it is already making a difference. It is giving children in Australia access to a trial and a potential treatment that simply isn’t available in other countries, giving them new hope and the opportunity to have treatment at home – which means a better quality of life with their family.”
Professor David Ziegler, Sydney Children’s Hospital, Randwick
Funding
achievements
$1.2M+ to Sydney Children’s Hospital, Randwick
World's First DART Deflexifol at Relapse Trial
In 2022, we were delighted to be approached by Professor David Ziegler at Sydney Children’s Hospital, Randwick, to provide $1,262,457 over five years as the principal funder of a world-first clinical trial into refractory or recurrent paediatric central nervous system tumours.
No other therapy exists for relapsed Ependymoma, and generally in this trial, patients are being treated at home rather than in hospital allowing more time together with family.
$1.5M to Sydney Children’s Hospital, Randwick
Kids with Cancer Foundation fully funded
the Cancer Research Unit.
$62,000 to The University of Melbourne
Funded a research assistant in 2004, allowing the Victoria Paediatric Cancer Family Study to continue its valuable work.
$312,955 to Children's Hospitals in NSW and QLD
In 2001, we funded Clinical Research Nurses and Research Psychologists at Sydney Children’s Hospital, Randwick and Queensland Children’s Hospital.
We also funded Data Manager and Late Effects Coordinator positions at Westmead Children’s Hospital.
$112,000 to The Children's Hospital at Westmead
In 1999, Kids with Cancer Foundation provided $150,000 to help start a Gene Therapy project supporting the work of Dr McCowage and Peter Gunning at The Children’s Hospital at Westmead.
Gene Therapy provides hope as a viable and innovative approach to the treatment of paediatric brain tumours and the alleviation of treatment side effects.
$30,000 to The Children's Hospital at Westmead
In 1998, funded a Data Manager to support cancer clinical trials.
